McCaul Touts Comprehensive Package to Combat Opioid Crisis
WASHINGTON, D.C. – Congressman Michael McCaul (R-TX), Chairman of the House Homeland Security Committee and a senior member of the House Foreign Affairs Committee, applauds the House passage of H.R. 6, the SUPPORT for Patients and Communities Act. This legislation was passed with overwhelming bipartisan support and now heads to the U.S. Senate.
Congressman McCaul: “While we are taking many positive steps towards combatting the opioid epidemic, we must continue do more. That is why I was proud to support this comprehensive package that targets the epidemic across multiple agencies. By focusing our federal efforts, and providing improved tools and resources to those fighting on the front lines in our local towns and communities, we will be able to address the systemic issues that contribute to this crisis.
“I’m glad to see we are diligently working to end the flow of illegal drugs entering into our country. By doing so, we will allow more Americans to follow their dreams and build a brighter future. I look forward to our continued work in the Congress to eradicate the scourge of opioids across our nation.”
Here are a few of the pieces of opioid legislation included in H.R. 6:
- H.R. 5788 – the Securing the International Mail Against Opioids Act of 2018 (STOP Act). According to the Department of Homeland Security (DHS), about 340 million packages enter the United States through the international mail stream with little or no electronic manifest data associated with them. Drug dealers know this and use the global postal system to deliver their deadly goods into our homes and communities. Private carriers are already subject to these requirements and McCaul has been long advocating for this change to how USPS handles international mail.
- H.R. 2851 – the Stop the Importation and Trafficking of Synthetic Analogues Act (SITSA Act). This legislation will improve the U.S. Attorney General’s ability to schedule a new dangerous drug in a matter of months when it is virtually identical to a currently scheduled drug. This will stop the unlawful importation and distribution of synthetic drugs.
- H.R. 5806 – the 21st Century Tools for Pain and Addiction Treatment Act. This legislation directs the Food and Drug Administration (FDA) to issue or update guidance on ways existing pathways can be used to bring novel non-addictive treatments for pain and addiction to patients. Several approaches have proven successful in speeding the availability of treatments for serious conditions through the FDA.
- H.R. 5580 – the STOP Fentanyl Deaths Act of 2018. This legislation authorizes grants to state and local agencies for the establishment or operation of public health laboratories to detect fentanyl, its analogues, and other synthetic opioids.